Advisory Services Network’s Gyre Therapeutics GYRE Stock Holding History

Advisory Services Network’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$460	Buy	+66	New	+$513	﹤0.01%	4438
2025 Q4	–	Sell	-66	Closed	-$492	–	2856
2025 Q3	$492	Buy	+66	New	+$501	﹤0.01%	4057
2024 Q1	–	Sell	-66	Closed	-$1.7K	–	2374
2023 Q4	$1.7K	Buy	+66	New	+$936	﹤0.01%	3430
2023 Q2	–	Sell	-67	Closed	-$207	–	2360
2023 Q1	$207	Sell	67 -66	-50%	-$251	﹤0.01%	3838
2022 Q4	$528	Buy	+133	New	+$543	﹤0.01%	3731
2021 Q3	–	Sell	-2,627	Closed	-$85K	–	2181
2021 Q2	$85K	Buy	+2,627	New	+$90.2K	﹤0.01%	1704

Other funds holding GYRE

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Advisory Services Network's GYRE Position: Q1 2026 in Review

Advisory Services Network opened a new position in Gyre Therapeutics (GYRE) in Q1 2026: 66 shares worth $460. The stake represents ﹤0.01% of the portfolio and ranks #4438 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in GYRE as recently as Q3 2025.

Advisory Services Network first reported a position in GYRE in Q2 2021 and has held it in 6 quarters since. The position peaked at $85K in Q2 2021. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

Advisory Services Network held 66 shares of Gyre Therapeutics worth $460 as of Q1 2026.
Gyre Therapeutics was a new Advisory Services Network position in Q1 2026.
Gyre Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4438 holding.
Advisory Services Network first reported a position in Gyre Therapeutics in Q2 2021 and has held it in 6 quarters since.
Advisory Services Network's Gyre Therapeutics position peaked at $85K in Q2 2021.
56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.